Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
DNA Script Expands Series B to $89M
Company Info
Company news
Tue, 12 Apr 2022 07:00:00 GMT
DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology - Business Wire
Fri, 07 Jul 2023 07:00:00 GMT
Multiplex enzymatic synthesis of DNA with single-base resolution - Science
Tue, 15 Jun 2021 07:00:00 GMT
DNA Script Announces the Commercial Launch of the SYNTAX System, the First Benchtop DNA Printer Powered by Enzymatic Synthesis, to Accelerate Molecular Biology and Genomics Workflows - PR Newswire
Sat, 25 Jun 2022 07:00:00 GMT
Democratized DNA Synthesis: A Game-Changer Against Covid-19 - Labiotech.eu
Tue, 04 Jul 2023 07:00:00 GMT
Assessment of enzymatically synthesized DNA for gene assembly - Frontiers
Tue, 11 Aug 2020 07:00:00 GMT
DNA Script Develops World’s First Enzymatic DNA Printer - Nanalyze
Wed, 02 Feb 2022 08:00:00 GMT
DNA Script Joins Wellcome Leap R3 Program to Advance RNA Products and Therapies - Business Wire
Thu, 17 Oct 2024 07:00:00 GMT
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform - Business Wire
Tue, 08 Mar 2022 08:00:00 GMT
DNA Script Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022 - Business Wire
Thu, 16 May 2019 07:00:00 GMT
DNA Script Raises $38.5 Million in Series B Financing - Business Wire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.